By Will Feuer

The Food and Drug Administration authorized Altria Group Inc.-owned U.S. Smokeless Tobacco Co.'s Copenhagen Classic Snuff product to be marketed as a modified-risk tobacco product, or MRTP.

The authorization means that the product, which is a smokeless tobacco product, can be marketed with the language: "IF YOU SMOKE, CONSIDER THIS: Switching completely to this product from cigarettes reduces risk of lung cancer."

The FDA said its staff reviewed available evidence, public comments and recommendations from expert committees and concluded that the claim in the language is accurate.

The company is still required to conduct postmarket surveillance. The modified-risk granted order will expire in five years and the company will need to receive authorization then to continue to market the product as a MRTP, the FDA said.

Write to Will Feuer at Will.Feuer@wsj.com

(END) Dow Jones Newswires

March 16, 2023 12:02 ET (16:02 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Altria (NYSE:MO)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024 Click aqui para mais gráficos Altria.
Altria (NYSE:MO)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024 Click aqui para mais gráficos Altria.